September 22, 2026 — RNews

#her2 — Tuesday, September 22, 2026 (1 items)

hot top new

← prev day next day →

0

Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial. (nature.com)

Lee CK … Choi HJ Nature Medicine 2026-09-22

#cancer #clinical trial #immunotherapy #chemotherapy #her2